文献速递鼻科

翼管神经切断术治疗慢性鼻窦炎伴鼻息肉的有效性:系统评价与Meta分析

Effectiveness of Vidian Neurectomy in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-10-28

该系统评价与Meta分析检索6个数据库至2024年5月,纳入6项研究共407例慢性鼻窦炎伴鼻息肉患者,比较翼管神经切断术或鼻后神经切断术联合内镜鼻窦手术与单纯内镜鼻窦手术的疗效。结果显示联合神经切断术在改善Lund-Kennedy评分、生活质量和视觉模拟量表症状评分方面更优,且不显著增加鼻出血或干眼风险,两组复发率无差异。

要点

  • 联合神经切断术组Lund-Kennedy评分改善优于单纯手术组,SMD=0.7276,术后6、12、24个月均维持统计学显著改善。
  • 联合神经切断术组生活质量和VAS症状评分改善维持至术后12个月,但24个月时未维持优势。
  • 附加神经切断术未显著增加鼻出血(OR=0.9806)或干眼(OR=2.4194)风险,两组复发率无差异。

核心结论

  • 附加神经切断术在改善慢性鼻窦炎伴鼻息肉患者的内镜表现和症状方面显示出更好的疗效,似乎是一种安全有效的治疗方法。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、SCOPUS、Embase、Web of Science、Google Scholar和Cochrane六个数据库至2024年5月,纳入6项研究共407例患者。
  • 比较翼管神经切断术或鼻后神经切断术联合内镜鼻窦手术与单纯内镜鼻窦手术的效果。
  • 结局指标包括Lund-Kennedy评分、患者报告症状评分(VAS)、生活质量、不良反应及复发率。

主要发现

  • 神经切断术组Lund-Kennedy评分显著改善,SMD=0.7276(95%CI 0.5695; 0.8857),术后6、12、24个月均维持统计学显著改善。
  • 治疗组鼻窦炎相关生活质量改善更优,SMD=0.4540(95%CI 0.1784; 0.7297),维持至术后12个月,24个月时未维持。
  • 治疗组VAS评分改善更优,SMD=0.7096(95%CI 0.4356; 0.9837),维持至术后12个月,24个月时未维持。
  • 附加神经切断术未显著增加鼻出血风险,OR=0.9806(95%CI 0.2348; 4.0960)。
  • 附加神经切断术未显著增加干眼风险,OR=2.4194(95%CI 0.1114; 52.5255)。

临床怎么用

  • 原文结论认为附加神经切断术在改善内镜表现和症状方面显示出更好疗效,似乎是一种安全有效的治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the clinical efficacy of vidian neurectomy (VN) or posterior nasal neurectomy (PNN) combined with endoscopic sinus surgery (ESS) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). DATA SOURCES: A systematic search of six databases (PubMed, SCOPUS, Embase, Web of Science, Google Scholar, and Cochrane) was conducted to identify relevant studies up to May 2024. REVIEW METHODS: The effects of combining VN or PNN with ESS were evaluated in comparison to ESS alone. Outcomes were assessed by evaluating changes in Lund-Kennedy score, patient-reported symptom scores (VAS), quality of life, as well as adverse effects and recurrence rate of CRSwNP. RESULTS: A total of 6 studies, comprising 407 patients, were included in the analysis. The neurectomy group showed significant improvements in Lund-Kennedy score (SMD = 0.7276 [0.5695; 0.8857]), with statistically significant improvements maintained at 6, 12, and 24 months postoperatively. The treatment group maintained better improvements in sinusitis-related quality of life (SMD = 0.4540 [0.1784; 0.7297]) and VAS (SMD = 0.7096 [0.4356; 0.9837]) until 12 months postoperatively, but not at 24 months. Regarding adverse effects, additional neurectomy did not significantly induce epistaxis (odds ratio [OR] = 0.9806 [0.2348; 4.0960]) or dry eye (OR = 2.4194 [0.1114; 52.5255]) compared to the control group. On the other hand, there was no difference in the recurrence rate of CRSwNP between the 2 groups during the follow-up periods. CONCLUSION: Additional neurectomy shows better efficacy in improving endoscopic findings and symptoms in patients with CRSwNP and appears to be a safe and effective treatment.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Kim JS, Stybayeva G, Hwang SH, et al. Effectiveness of Vidian Neurectomy in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2024. PMID: 39467055. doi:10.1002/ohn.1037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。